2023 House Bill 4890

Health: pharmaceuticals; insulin production program; establish.

A bill to amend 1984 PA 270, entitled “Michigan strategic fund act,” by amending section 9 (MCL 125.2009), as amended by 2021 PA 136, and by adding chapter 8F.

House Fiscal Agency Analysis

Taken together, House Bills 4890 and 5519 would amend the Michigan Strategic Fund Act to require the Michigan Strategic Fund (MSF) to create and operate a program to make and distribute insulin in partnership with a private sector entity. The bills would provide requirements for contractors selected to be partners under the program, prescribe provisions to be included in contractor agreements, allow MSF to make grants related to the program, create the Insulin Production Fund, provide for a temporary insulin distribution program while a production facility is being built, and require MSF to include information about the program in its annual report.

Introduced in the House

July 18, 2023

Introduced by Rep. Curtis VanderWall (R-102) and six co-sponsors

Co-sponsored by Reps. Sharon MacDonell (D-56), Ken Borton (R-105), John Roth (R-104), Kathy Schmaltz (R-46), Gregory Alexander (R-98) and Brian BeGole (R-71)

Referred to the Committee on Health Policy

May 22, 2024

Reported with substitute H-2